Pamiparib Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Head and Neck CarcinomaHead and Neck CancerHead and Neck Squamous Cell Carcinoma+2 more
University of Chicago30 enrolled1 locationNCT05526924
Recruiting
Phase 2
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University40 enrolled1 locationNCT06387056